Assessment of beta2-microglobulin in cerebrospinal fluid is recommended within the enhanced level of examination [17]; β2-m concentrations in CSF have been proposed as a reliable marker in different inflammatory, autoimmune, or neoplastic central nervous system disorders. This evidence concerns the gene B2M and central nervous system disorder.